According to Wound Management Technologies, CellerateRx is FDA cleared as a medical device and is indicated for all acute and chronic wounds except for third degree burns.
Cathy Bradshaw, president of Wound Care Innovations, said: “We are excited about the opportunities presented by this relationship. It will enable us to facilitate government sales in the many inpatient and outpatient VA centers around the country as well as the other government agencies.”